Summer Sale: Save 51% on Pro and invest smartly

[edd_has_expired_licenses]

Summer Sale: Save 51% on Pro and invest smartly

[/edd_has_expired_licenses]

Pfizer’s Revenue Breakdown by Wholesaler (2013 – 2021)

Exclusive Data

You need the Pro Plan for unlimited access.

Pro Plan

$39 per month*

51% discount ends in:

00
Days
00
Hours
00
Mins.
00
Seconds

Download

About

This statistic highlights Pfizer’s Revenue Breakdown by Wholesaler from 2013 onwards, split across AmerisourceBergen, Cardinal Health, McKesson, and Others/Unclassified.
Subscribe to Pro or Enterprise plans to unlock this feature.
More information
Subscribe to Pro or Enterprise plans to unlock this feature.
Contact the Analyst
Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on reddit
Share on facebook
Share on twitter
Share on linkedin
Share on email

Become a smarter investor today.

Access Business Quant for as low as $19/month

Become a smarter investor today.

Access KPIs & Segment Financials on US stocks

This statistic highlights Pfizer’s Revenue Breakdown by Wholesaler from 2013 onwards split across AmerisourceBergen, Cardinal Health, McKesson, and Others/Unclassified.

Pfizer Inc. is a global biopharmaceutical company. Its revenue comes from the manufacture and sale of their products, mainly biopharmaceutical products, and, from alliance agreements, under which they co-promote products discovered or developed by them or other companies. They seek to promote wellness, prevention, treatments, and cures for the world’s most serious illnesses in developed and emerging economies.

Pfizer’s Revenue Breakdown by Wholesaler

Pfizer distributes its products through the following wholesalers:

  • AmerisourceBergen
  • Cardinal Health
  • McKesson
  • Others/Unclassified
Wholesaler Revenue in 2019 Revenue in 2020 Revenue share in 2020 YoY Growth
AmerisourceBergen $4.53 $5.45 13% 20%
Cardinal Health $3.71 $4.19 10% 13%
McKesson $6.18 $6.71 16% 9%
Others/Unclassified $26.76 $25.56 61% -4%
Total $41.17 $41.91 100% 2%

(All figures in billions, except percentages)

In 2020, the United States accounted for 52% of Pfizer’s revenue, while China and Japan each contributed 6% and other nations accounted for 36%.

Pfizer’s revenue is bifurcated among the following wholesalers:

AmerisourceBergen

AmerisourceBergen is a company based in the United States handling nearly 20% of all medications supplied in the United States. They offer drug distribution as well as medical business operations and patient care consultancy. AmerisourceBergen has 26 pharmaceutical distribution facilities in the United States and nine in Canada. They also have four specialized distribution facilities in the United States and more than one million square feet of packaging & manufacturing capacity in the United States and the United Kingdom.

Pfizer’s revenue from AmerisourceBergen stood at $5.45 billion in 2020. It witnessed a growth of 20% when compared to $4.53 billion earned in 2019. AmerisourceBergen accounted for 13% of Pfizer’s revenue in 2020.

Cardinal Health

Cardinal Health, Inc. is a worldwide healthcare services firm based in the United States that specializes in the distribution of medications and medical devices to over 100,000 locations. It has the country’s largest network of radiopharmacies. Over 75 per cent of hospitals in the United States use Cardinal Health’s medical products.

In 2020, Cardinal Health accounted for 10% of Pfizer’s revenue amounting to $4.19 billion. It was a 13% increase compared to $3.71 billion earned in the year 2019.

McKesson

McKesson Corporation is a pharmaceutical distributor and provides health information technology, medical supplies, and care management solutions, and large network infrastructure for the health care industry in the United States. A third of the drugs used in North America are delivered by this corporation.

Pfizer’s revenue from McKesson rose from $6.18 billion in 2019 to $6.71 billion in 2020, marking an increase of 9% on a year-on-year basis. McKesson contributed to 16% of Pfizer’s total revenue in 2020.

Others/Unclassified

Others/Unclassified consist of wholesalers who are not listed above. Pfizer’s other wholesalers include Amatheon Inc, AMD Pennsylvania LLC, Mountainside Medical Equipment Inc, Orion Medical Supply Inc, Caligor Pharmacy & Medical Supplies, Fisher Bioservices Rockville, National Cornerstone Healthcare Service Inc, Hanna’s Pharmaceutical Supply Co Inc, Medical Specialties Distributors LLC, and more.

Pfizer’s Others/Unclassified wholesalers generated $25.56 billion in revenue in 2020, down by 4% from $26.76 billion generated in 2019. Others/Unclassified wholesalers accounted for the majority of Pfizer’s sales in 2020, accounting for 61% of total revenue.

About Pfizer

Pfizer Inc. is an American-based pharmaceutical and biotechnology company. Their headquarters is situated in Manhattan, New York City. The company is named after its co-founder Charles Pfizer. Pfizer’s common stocks are traded on NYSE under the trading symbol ‘PFE’. On the Fortune 500, the company is ranked 64th, while on the Forbes Global 2000, it is ranked 49th. As of 2020, the number of employees of the company worldwide was 78,000.

Pfizer Inc. uses science and its global resources to bring therapies to people around the world that extend and improve their lives through the invention, advancement, production, marketing, sales, and distribution of biopharmaceutical products. They work with healthcare professionals, governments, and local communities all around the globe to promote and extend access to safe, affordable healthcare.

Over the years, Pfizer has acquired many companies such as Warner-Lambert, Pharmacia, Wyeth, King pharmaceuticals, Anacor pharmaceuticals, Arixa Pharmaceuticals, and Amplyx Pharmaceuticals. Pfizer and BioNTech signed an agreement for the production of the COVID-19 vaccine in March 2020. GlaxoSmithKline, AbbVie, Merck & Co., Eli Lilly & Co., Bristol Myers Squibb, Novartis AG, and Johnson & Johnson are among Pfizer’s top competitors.

Did you like Pfizer’s Revenue Breakdown by Wholesaler statistic?

Access thousands of more such key performance indicator data points, on listed companies, with Business Quant.

You can also get started for free.

Read more

Access Segment financials and KPI data on US stocks

Our Plans

Always know what you’ll pay. No hidden costs or surprises.

  • Annual
  • Monthly

Basic

Get to know us

  • Access basic data
  • No credit card required
$0
per month
Start for Free

51% discount until October 31

Pro

For serious investing

  • Granular KPI data Access segment financials, non-GAAP metrics and KPI data from presentations and filings. Examples include financials by segment / region / product category, AT&T's broadband subscriber trends, Tesla's deliveries by model and lots more.
  • Stock research tools Features include : Stock screener, Stock comparison, sector financials, stock warnings, advanced charting tools, financial statements dating back 10+ years, stock reports, SEC filings and stock ratings. There are 200+ financial items and ratios on thousands of US stocks.
  • Industry data & tools Access premium operating data on 40+ industries. Examples include market share, smartphone shipments by vendor, subscribers by wireless carrier, historical gold production. There are 20,000+ such statistics.
$39
$19
per month*
Buy Now

Enterprise

For tailored workflows

  • All of Pro plan Get unfettered access to all our dashboards and dossiers.
  • Custom built features Get tailored dashboards built specially for you , based on your set of requirements, to simplify your research workflow.
$99
per month, onwards*
Contact Us

* Billed annually, local taxes extra. 

Basic

Get to know us

  • Access basic data
  • No credit card required
$0
per month
Start for Free

51% discount on Annual plan

Pro

For serious investing

  • Granular KPI data Access segment financials, non-GAAP metrics and KPI data from presentations and filings. Examples include financials by segment / region / product category, AT&T's broadband subscriber trends, Tesla's deliveries by model and lots more.
  • Stock research tools Features include : Stock screener, Stock comparison, sector financials, stock warnings, advanced charting tools, financial statements dating back 10+ years, stock reports, SEC filings and stock ratings. There are 200+ financial items and ratios on thousands of US stocks.
  • Industry data & tools Access premium operating data on 40+ industries. Examples include market share, smartphone shipments by vendor, subscribers by wireless carrier, historical gold production. There are 20,000+ such statistics.
$39
per month*
Buy Now

Enterprise

For tailored workflows

  • All of Pro plan Get unfettered access to all our features.
  • Custom built features Get tailored dashboards built specially for you , based on your set of requirements, to simplify your research workflow.
$99
per month, onwards*
Contact Us

* Local taxes extra. 

BQ Star 51% off

Get Pro for 51% off

  • Access all features immediately
  • Datasets updated every day
  • Export data in CSV and XLSX formats

Offer Ends In

Starting from $39 $19 / month

.